Table 1 Summary Statistics of All Variables

Panel A: N = 976

Mean

St. dev.

Baseline Payment (U.S. $)

2.02

3.13

Affected by Merger (%)

0.10

0.30

Average HHI

4839.81

1992.38

Average Doses per quarter (n)

1,345,944.0

3,058,184.0

Average share of branded in market (%)

0.12

0.14

Panel B: N = 976

Frequency

%

Number of Labelers (Reference: 0–4) 0–4

318

32.58

 5–9

412

42.21

 10+

246

25.20

Therapeutic Group (Reference: Miscellaneous) Anti-Infective

113

11.58

 Cancer

10

1.02

 Cardiovascular

218

22.34

 CNS

343

35.14

 Hormones

93

9.53

 Immunosuppressant

7

0.72

 Misc.

192

19.67

Maintenance Group (Reference: Both Chronic and Acute) Both

411

42.11

 Prim. Acute

349

35.76

 Prim. Chronic

208

21.31

 Missing/Other

8

0.82